Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

New Owner

AbbVie - Stemcentrx

AbbVie acquires Stemcentrx

Announced: April 28, 2016

Type:           Acquisition
Disposition: Separate Entity
Terms:         Cash & Stock
Status:         Complete

Amount:       $ 5,800,000,000

Acquisition News

Add News

Date Title
There are no news.

AbbVie Other Acquisitions

Add Acquisition

Date Acquired Amount
Mar 04, 2015
Pharmacyclics
$ 21,000,000,000
Jan 01, 2014
ImmuVen
Undisclosed amount